Evidence map›Paper›PMID 30672370›Full record

ArticleJournal of neurotrauma2019

Bisperoxovanadium Mediates Neuronal Protection through Inhibition of PTEN and Activation of PI3K/AKT-mTOR Signaling after Traumatic Spinal Injuries.

Chandler L Walker, Xiangbing Wu, Nai-Kui Liu, Xiao-Ming Xu

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. 5-HTFrontiers in cellular neuroscience · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Valproic Acid: A Potential Therapeutic for Spinal Cord Injury.Cellular and molecular neurobiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chandler L WalkerDepartment of Biomedical and Applied Sciences, Indiana University School of Dentistry, Indianapolis, Indiana.
Xiangbing WuSpinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery and Goodman Campbell Brain and Spine, Indiana University School of Medicine, Indianapolis, Indiana.
Nai-Kui LiuSpinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery and Goodman Campbell Brain and Spine, Indiana University School of Medicine, Indianapolis, Indiana.
Xiao-Ming XuSpinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Department of Neurological Surgery and Goodman Campbell Brain and Spine, Indiana University School of Medicine, Indianapolis, Indiana.
Indiana University – Purdue University Indianapolis · US

Funding

Modulation of lumbar motor circuitry after an above-level SCI and NT-3 gene therapyR01NS103481 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI SMITH, GEORGE M, WU, WEI · 2017 to 2021
$1.9M
Constructing a growth-promoting pathway for functional regeneration after SCII01BX002356 · VA · RLR VA MEDICAL CENTER · PI BROWN, TODD J, JONES, KATHRYN JANE · 2015 to 2023
–
Cardiolipin as a Novel Target for Neuroprotection after Spinal Cord InjuryI01BX003705 · VA · RLR VA MEDICAL CENTER · PI XU, XIAO-MING · 2018 to 2021
–
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALSIK2RX002688 · VA · RLR VA MEDICAL CENTER · PI WALKER, CHANDLER · 2019 to 2023
–
BLRD VA I01 BX002356BLRD VA I01 BX003705NINDS NIH HHS R01 NS103481RRD VA IK2 RX002688
6 · The paper itself

Abstract

Although mechanisms involved in progression of cell death in spinal cord injury (SCI) have been studied extensively, few are clear targets for translation to clinical application. One of the best-understood mechanisms of cell survival in SCI is phosphatidylinositol-3-kinase (PI3K)/Akt and associated downstream signaling. Clear therapeutic efficacy of a phosphatase and tensin homologue (PTEN) inhibitor called bisperoxovanadium (bpV) has been shown in SCI, traumatic brain injury, stroke, and other neurological disease models in both neuroprotection and functional recovery. The present study aimed to elucidate mechanistic influences of bpV activity in neuronal survival in

Indexed as

AnimalsCells, CulturedFemaleNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseRatsRats, Sprague-DawleySignal TransductionSpinal Cord InjuriesTOR Serine-Threonine KinasesVanadium CompoundsbisperoxovanadiummTOR protein, ratNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, ratTOR Serine-Threonine KinasesVanadium CompoundsbisperoxovanadiumbpVmTOR spinal cord injuryneuroprotectionPTEN

Identifiers

PMID30672370
PMCPMC6727469
OpenAlexW2913428618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.